These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 21749622)

  • 1. Re: Comparing medical versus surgical termination of pregnancy at 13-20 weeks of gestation: a randomised controlled trial.
    Lyus R
    BJOG; 2011 Aug; 118(9):1148-9. PubMed ID: 21749622
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparing medical versus surgical termination of pregnancy at 13-20 weeks of gestation: a randomised controlled trial.
    Kelly T; Suddes J; Howel D; Hewison J; Robson S
    BJOG; 2010 Nov; 117(12):1512-20. PubMed ID: 20860598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised controlled trial comparing the efficacy of same-day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36 to 48 hour protocol.
    Guest J; Chien PF; Thomson MA; Kosseim ML
    BJOG; 2007 Feb; 114(2):207-15. PubMed ID: 17305893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Misoprostol dose and route after mifepristone for early medical abortion: a randomised controlled noninferiority trial.
    von Hertzen H; Huong NT; Piaggio G; Bayalag M; Cabezas E; Fang AH; Gemzell-Danielsson K; Hinh ND; Mittal S; Ng EH; Chaturachinda K; Pinter B; Puscasiu L; Savardekar L; Shenoy S; Khomassuridge A; Tuyet HT; Velasco A; Peregoudov A;
    BJOG; 2010 Sep; 117(10):1186-96. PubMed ID: 20560941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised controlled trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion up to 13 weeks of gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    BJOG; 2005 Aug; 112(8):1102-8. PubMed ID: 16045525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mifepristone plus vaginal misoprostol vs vaginal misoprostol alone for medical abortion in gestation 63 days or less in Nepalese women: a quasi-randomized controlled trial.
    Chawdhary R; Rana A; Pradhan N
    J Obstet Gynaecol Res; 2009 Feb; 35(1):78-85. PubMed ID: 19215552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial.
    von Hertzen H; Piaggio G; Wojdyla D; Marions L; My Huong NT; Tang OS; Fang AH; Wu SC; Kalmar L; Mittal S; Erdenetungalag R; Horga M; Pretnar-Darovec A; Kapamadzija A; Dickson K; Anh ND; Tai NV; Tuyet HT; Peregoudov A;
    BJOG; 2009 Feb; 116(3):381-9. PubMed ID: 19187370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mifepristone and misoprostol for cervical ripening in surgical abortion between 12 and 14 weeks of gestation: a randomized controlled trial.
    Ohannessian A; Baumstarck K; Maruani J; Cohen-Solal E; Auquier P; Agostini A
    Eur J Obstet Gynecol Reprod Biol; 2016 Jun; 201():151-5. PubMed ID: 27132200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mifepristone in combination with prostaglandins for termination of 10-16 weeks' gestation: a systematic review.
    Chen QJ; Hou SP; Meads C; Huang YM; Hong QQ; Zhu HP; Cheng LN;
    Eur J Obstet Gynecol Reprod Biol; 2011 Dec; 159(2):247-54. PubMed ID: 21741747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study on the combined use of letrozole, mifepristone and misoprostol in termination of first trimester pregnancy up to 9 weeks' gestation.
    Chai J; Ho PC
    Eur J Obstet Gynecol Reprod Biol; 2013 Dec; 171(2):291-4. PubMed ID: 24135383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequency and risk factors for repeat abortions after surgical compared with medical termination of pregnancy.
    Niinimäki M; Pouta A; Bloigu A; Gissler M; Hemminki E; Suhonen S; Heikinheimo O
    Obstet Gynecol; 2009 Apr; 113(4):845-852. PubMed ID: 19305329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomised preference trial of medical versus surgical termination of pregnancy less than 14 weeks' gestation (TOPS).
    Robson SC; Kelly T; Howel D; Deverill M; Hewison J; Lie ML; Stamp E; Armstrong N; May CR
    Health Technol Assess; 2009 Nov; 13(53):1-124, iii-iv. PubMed ID: 19906334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two medical abortion regimens for late first-trimester termination of pregnancy: a prospective randomized trial.
    Dalenda C; Ines N; Fathia B; Malika A; Bechir Z; Ezzeddine S; Hela C; Badis CM
    Contraception; 2010 Apr; 81(4):323-7. PubMed ID: 20227549
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The combination of mifepristone and misoprostol for the termination of pregnancy.
    ;
    Int J Gynaecol Obstet; 2011 Oct; 115(1):1-4. PubMed ID: 21872858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One- and two-day dosing intervals between mifepristone and misoprostol in second trimester medical termination of pregnancy--a randomized trial.
    Mentula M; Suhonen S; Heikinheimo O
    Hum Reprod; 2011 Oct; 26(10):2690-7. PubMed ID: 21798991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mifepristone versus vaginally administered misoprostol for cervical priming before first-trimester termination of pregnancy: a randomized, controlled study.
    Ashok PW; Flett GM; Templeton A
    Am J Obstet Gynecol; 2000 Oct; 183(4):998-1002. PubMed ID: 11035353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomised controlled trial comparing efficacy of same day administration of mifepristone and misoprostol for termination of pregnancy with the standard 36- to 48-hour protocol.
    Guest J; Chien P; Thomson M; Kosseim ML
    BJOG; 2005 Oct; 112(10):1457. PubMed ID: 16167962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mifepristone and second trimester pregnancy termination for fetal abnormality in Western Australia: Worth the effort.
    Dickinson JE; Brownell P; McGinnis K; Nathan EA
    Aust N Z J Obstet Gynaecol; 2010 Feb; 50(1):60-4. PubMed ID: 20218999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomized trial of mifepristone in combination with misoprostol administered sublingually or vaginally for medical abortion at 13-20 weeks gestation.
    Hamoda H; Ashok PW; Flett GM; Templeton A
    Hum Reprod; 2005 Aug; 20(8):2348-54. PubMed ID: 15878927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re: Using telemedicine for termination of pregnancy with mifepristone and misoprostol in settings where there is no access to safe services.
    Gomperts R; Kleiverda G; Gemzell K; Davies S; Jelinska K
    BJOG; 2008 Nov; 115(12):1578-9. PubMed ID: 19035995
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.